Dashboard
Weak Long Term Fundamental Strength with a 7.92% CAGR growth in Net Sales over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.83
- The company has been able to generate a Return on Equity (avg) of 7.27% signifying low profitability per unit of shareholders funds
Stock is technically in a Mildly Bearish range
With ROCE of 10.1, it has a Fair valuation with a 1.3 Enterprise value to Capital Employed
Falling Participation by Institutional Investors
Stock DNA
Petrochemicals
INR 1,367 Cr (Small Cap)
29.00
44
0.43%
0.16
4.73%
1.27
Total Returns (Price + Dividend) 
Latest dividend: 0.1 per share ex-dividend date: Feb-20-2026
Risk Adjusted Returns v/s 
Returns Beta
News

DCW Ltd Upgraded from Strong Sell to Sell on Improved Valuation and Financial Metrics
DCW Ltd, a small-cap player in the petrochemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 18 May 2026. This change reflects a notable improvement in valuation metrics alongside mixed signals from financial trends and technical indicators. Despite ongoing challenges in long-term fundamentals and institutional participation, the revised rating signals a cautious optimism among analysts.
Read More
DCW Ltd Valuation Shifts to Fair Amidst Market Volatility
DCW Ltd, a small-cap player in the petrochemicals sector, has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite a recent downgrade in its overall Mojo Grade to Strong Sell, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more attractive entry point relative to its historical averages and peer group, signalling a complex but potentially opportunistic scenario for investors.
Read More Announcements 
Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026
05-Aug-2026 | Source : BSEDCW Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company along with the Limited Review Report thereon for the quarter ended June 30 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
05-Aug-2026 | Source : BSEIntimation of proposed schedule of Earnings Conference Call for Investor(s)/Analyst(s) under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
03-Aug-2026 | Source : BSESuspension of operations due to flooding and heavy rains at the Dhrangadhra Plant of the Company
Corporate Actions 
13 Aug 2026
DCW Ltd has declared 5% dividend, ex-date: 20 Feb 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Non Institution
3.8214
Held by 5 Schemes (0.0%)
Held by 43 FIIs (6.12%)
Ashish Jain (10.97%)
Eriska Investment Fund Ltd (2.77%)
33.97%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 17.17% vs -3.60% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 268.98% vs -64.52% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 2.68% vs 15.98% in Sep 2024
Growth in half year ended Sep 2025 is 359.85% vs -56.68% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 4.93% vs 17.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 59.26% vs 5,627.27% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 7.16% vs 6.88% in Mar 2025
YoY Growth in year ended Mar 2026 is 60.19% vs 92.02% in Mar 2025